HZNP - Horizon Therapeutics Non-GAAP EPS of $1.20 beats by $0.23 revenue of $945M beats by $71.49M
2023-08-08 07:05:32 ET
- Horizon Therapeutics press release ( NASDAQ: HZNP ): Q2 Non-GAAP EPS of $1.20 beats by $0.23 .
- Revenue of $945M (+7.8% Y/Y) beats by $71.49M .
- The company expects to advance its global expansion strategy, with multiple planned international launches in 2023.
- It also continues to make progress on its two Phase 3 programs in IgG4-related disease (IgG4-RD) and myasthenia gravis ( MG ).
For further details see:
Horizon Therapeutics Non-GAAP EPS of $1.20 beats by $0.23, revenue of $945M beats by $71.49M